MarketFriction

Eiko Lifesciences Ltd

BSE 540204 · Specialty Chemicals
₹48.67 -2.19%
BSE close2026-10-01
Market cap₹75.8 Cr.
P/E15.5

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Mar 2020Jun 2020Sep 2020Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.620.560.8410.758.167.4911.2710.7111.6711.9818.3416.75
Expenses1.530.420.8910.357.736.869.959.209.9010.1016.0814.82
Operating Profit-0.910.14-0.050.400.430.631.321.511.771.882.261.93
OPM %-146.77%25.00%-5.95%3.72%5.27%8.41%11.71%14.10%15.17%15.69%12.32%11.52%
Other Income-0.040.050.010.260.130.120.640.270.300.350.130.45
Interest0.030.010.100.030.040.030.070.050.100.070.120.13
Depreciation0.050.040.040.170.160.160.250.250.260.260.250.25
Profit before tax-1.030.14-0.180.460.360.561.641.481.711.902.022.00
Tax %-28.16%28.57%-22.22%26.09%27.78%25.00%23.78%25.00%24.56%24.74%25.74%24.50%
Net Profit-0.740.10-0.130.370.280.421.251.111.291.431.501.51
EPS in Rs-0.640.09-0.080.300.220.330.840.660.790.880.910.91
Mar 2018Mar 2019Mar 2020Mar 2025Mar 2026TTM
Sales2.364.2710.4037.6652.5758.74
Expenses1.984.9514.9134.8945.2450.90
Operating Profit0.38-0.68-4.512.777.337.84
OPM %16.10%-15.93%-43.37%7.36%13.94%13.35%
Other Income0.040.040.011.201.161.23
Interest0.090.190.240.170.360.42
Depreciation0.080.170.190.741.021.02
Profit before tax0.25-1.00-4.933.067.117.63
Tax %20.00%-21.00%-26.77%24.51%25.18%
Net Profit0.20-0.78-3.622.325.325.73
EPS in Rs0.31-0.69-2.981.863.713.49
Dividend Payout %0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%56%
Compounded Profit Growth%%%102%
Stock Price CAGR%-8%-4%0%
Return on Equity%%%8%
Mar 2018Mar 2019Mar 2020Mar 2025Mar 2026
Equity Capital3.823.823.8213.7614.35
Reserves1.741.10-0.8743.0354.44
Borrowings1.741.371.612.764.73
Other Liabilities3.663.017.496.5615.85
Total Liabilities10.969.3012.0566.1189.37
Fixed Assets1.681.711.7523.1222.10
CWIP0.000.000.000.000.00
Investments3.171.720.107.1515.29
Other Assets6.115.8710.2035.8451.98
Total Assets10.969.3012.0566.1189.37
Mar 2018Mar 2019Mar 2020Mar 2025Mar 2026
Cash from Operating Activity0.000.16-0.332.782.25
Cash from Investing Activity0.00-0.30-0.71-11.30-8.63
Cash from Financing Activity0.00-0.550.956.968.21
Net Cash Flow0.00-0.69-0.09-1.571.83
Free Cash Flow0.00-0.04-0.56-7.512.25
CFO/OP0%-26%7%112%50%
Mar 2018Mar 2019Mar 2020Mar 2025Mar 2026
Debtor Days225.8173.5141.41104.58140.39
Inventory Days819.93287.76153.9664.4835.09
Days Payable605.69174.40184.6636.99111.03
Cash Conversion Cycle440.04186.8710.72132.0764.46
Working Capital Days80.42-1.71-151.62143.73127.89
ROCE %-11.83%-105.39%11.12%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters24.23%24.23%24.23%24.40%24.40%31.27%36.23%36.74%37.17%37.17%39.91%39.91%
Public75.77%75.77%75.76%75.59%75.59%68.73%63.78%63.26%62.81%62.83%60.09%60.09%
No. of Shareholders2,7222,6372,9132,9383,1403,4563,3363,3223,1503,0922,9693,019

Fundamentals

Market Cap₹ 75.8 Cr.
Current Price₹ 51.8
Stock P/E15.5
Book Value₹ 48.0
ROCE11.1 %
ROE8.47 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)56%
Compounded Profit Growth (TTM)102%
Consolidated figures.
Ownership
Promoter holding39.91% (+3.17 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Period540204Nifty 50Difference
1 week-6.8%-2.8% -4.1 pts
1 month+3.5%-6.8% +10.3 pts
3 months-3.5%-7.6% +4.1 pts
3 years-18.4%+14.2% -32.6 pts
5 years-38.3%+27.9% -66.2 pts

Red flags

No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹17 Cr +56.4% vs Jun 2025. Net profit ₹2 Cr +36.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Pidilite Industries Ltd148,80956.231.0 %
Gujarat Fluorochemicals Ltd48,40278.49.64 %
Navin Fluorine International Ltd42,25553.121.0 %
Aether Industries Ltd23,22696.811.9 %
Deepak Nitrite Ltd20,85426.311.4 %
Atul Ltd17,61422.114.9 %
Aarti Industries Ltd17,04532.66.86 %
Fine Organic Industries Ltd15,75936.021.5 %
BASF India Ltd14,87124.014.5 %
Privi Speciality Chemicals Ltd14,08440.322.3 %
Anupam Rasayan India Ltd13,40976.87.38 %
Vinati Organics Ltd12,17324.421.4 %
Elantas Beck India Ltd10,82060.921.2 %
Jubilant Ingrevia Ltd10,18032.011.4 %
Alkyl Amines Chemicals Ltd9,11140.516.6 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Eiko Lifesciences Ltd?

Eiko Lifesciences Ltd (540204) has a market capitalisation of Rs 75.8 Cr. at the 2026-10-01 close.

What is the P/E ratio of Eiko Lifesciences Ltd?

Eiko Lifesciences Ltd trades at a P/E of 15.5 on trailing twelve-month profit, at the 2026-10-01 close.

What were Eiko Lifesciences Ltd's latest quarterly results?

In the Jun 2026 quarter, Eiko Lifesciences Ltd sales was Rs 17 Cr (+56.4% vs Jun 2025) and net profit was Rs 2 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03